Pages that link to "Q71645386"
Jump to navigation
Jump to search
The following pages link to 5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects (Q71645386):
Displaying 34 items.
- Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies (Q31125310) (← links)
- Ovarian steroids and serotonin neural function (Q33538362) (← links)
- The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review. (Q33619940) (← links)
- Conventional and new antidepressant drugs in the elderly (Q33869435) (← links)
- Aggression, suicidality, and intermittent explosive disorder: serotonergic correlates in personality disorder and healthy control subjects (Q34660742) (← links)
- Serotonergic and noradrenergic function in depression: clinical correlates (Q35236257) (← links)
- Corticosteroid-serotonin interactions in depression: a review of the human evidence. (Q35685169) (← links)
- Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses (Q35687722) (← links)
- Associations among central nervous system serotonergic function and neuroticism are moderated by gender (Q36740451) (← links)
- Serum prolactin levels and sexual dysfunctions in antipsychotic medication, such as risperidone: a review (Q38774790) (← links)
- Lack of effect of HPA axis hyperactivity on hormonal responses to d-fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour. (Q43597637) (← links)
- Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder (Q43722416) (← links)
- Is long-term heavy alcohol consumption toxic for brain serotonergic neurons? Relationship between years of excessive alcohol consumption and serotonergic neurotransmission (Q43842930) (← links)
- Risperidone-induced increase in serum prolactin is correlated with positive symptom improvement in chronic schizophrenia (Q43963204) (← links)
- Prolactin responses to acute clomipramine and haloperidol of male schizophrenic patients in a drug-free state and after treatment with clozapine or with olanzapine (Q44041606) (← links)
- Modulation of stress-induced and stimulated hyperprolactinemia with the group II metabotropic glutamate receptor selective agonist, LY379268. (Q44182691) (← links)
- Endocrinological effects of mirtazapine in healthy volunteers (Q44262057) (← links)
- Dopamine and serotonin function in untreated schizophrenia: clinical correlates of the apomorphine and d-fenfluramine tests. (Q44426817) (← links)
- Plasma oxytocin in response to pharmaco-challenge to D-fenfluramine and placebo in healthy men. (Q44473310) (← links)
- Serum cholesterol and serotonergic function in major depressive disorder (Q44473312) (← links)
- Tobacco use is associated with reduced central serotonergic neurotransmission in type 1 alcohol-dependent individuals (Q44579531) (← links)
- Comorbidity of alcohol dependence with attention-deficit hyperactivity disorder: differences in phenotype with increased severity of the substance disorder, but not in genotype (serotonin transporter and 5-hydroxytryptamine-2c receptor). (Q44628774) (← links)
- 5HT-2C receptor polymorphism in suicide victims. Association studies in German and Slavic populations. (Q45017086) (← links)
- Thyroid axis activity and serotonin function in major depressive episode (Q48133466) (← links)
- Psychoneuroendocrinology of depression. Prolactin (Q48427588) (← links)
- Serotonin function and antiaggressive response to fluoxetine: A pilot study (Q48622004) (← links)
- Prolactin response to D-fenfluramine in outpatients with major depression (Q50870576) (← links)
- Prolactin response to D-fenfluramine challenge test as a predictor of treatment response to haloperidol in acute schizophrenia (Q50896516) (← links)
- Fenfluramine challenge in unipolar depression with and without anger attacks (Q51081196) (← links)
- Serotonergic dysfunction in women with pure premenstrual dysphoric disorder: is the fenfluramine challenge test still relevant? (Q54649529) (← links)
- Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia (Q73477695) (← links)
- Serotonin function in human subjects: intercorrelations among central 5-HT indices and aggressiveness (Q74176260) (← links)
- Prolactin response to d-fenfluramine in major depression before and after treatment with serotonin reuptake inhibitors (Q74451214) (← links)
- 5-HT2c agonist, lorcaserin, reduces aggressive responding in intermittent explosive disorder: A pilot study (Q91487374) (← links)